ESR1 and triple-negative breast carcinoma: To test whether caffeine, cisplatin or the combination of both induced cell death with the triple-negative breast cancer cell line (MDA-MB-231), estrogen-receptor lacking breast cancer line (MCF7) and normal breast epithelial cell line (MCF10A), cell viability was examined by trypan blue exclusion.